<DOC>
	<DOCNO>NCT01083888</DOCNO>
	<brief_summary>To assess Pharmacokinetics pharmacodynamics single dos ASP1517 renal anemia patient hemodialysis . Safety tolerability also evaluate patient .</brief_summary>
	<brief_title>ASP1517 Pharmacokinetics Study Anemia Patients Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Chronic renal failure patient receive hemodialysis thrice weekly Body weight : &gt; =40.0 &lt; 80.0 kg Mean hemoglobin level &gt; =10.0 = &lt; 12.0 g/dL Patients severe inflammation infection Patients medical history gastrointestinal surgery enterectomy Patients uncontrolled hypertension Patients whose AST , ALT , total bilirubin , GGT exceed ULN medical history serious liver diseases Patients medical history severe cardiac cerebrovascular diseases Patients receive blood transfusion surgery ( except surgery shunt ) within 4 week Patients medical history serious drug allergy Patients may pregnant lactating , refuse use require birth control study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Safety tolerability</keyword>
	<keyword>Plasma concentration</keyword>
	<keyword>ASP1517</keyword>
	<keyword>FG-4592</keyword>
</DOC>